Login to Your Account

Inhibiting Oncogenes

Mirna Puts First MicroRNA Mimic into the Clinic

By Brian Orelli
BioWorld Insight Contributing Writer

Monday, May 20, 2013

Mirna Therapeutics Inc. announced last week that it has initiated a Phase I trial of MRX34, its microRNA (miRNA) mimic. Andreas Bader, director of research at Mirna, told BioWorld Insight the company believes it's the first miRNA mimic to enter the clinic.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription